Navigation Links
Apama Medical, A Shifamed Portfolio Company, Closes $3.2M Series A-1 Financing Round
Date:9/16/2013

CAMPBELL, Calif., Sept. 16, 2013 /PRNewswire/ -- Shifamed LLC, a medical technology incubator, announced today that Apama Medical, Inc., one of its privately held portfolio companies, has raised $3.2M in Series A-1 financing.

Broadview Ventures led the financing round and converted its initial investment to Series A-1 equity. Broadview is a Boston-based investment firm focused on accelerating the development of promising technology in cardiovascular and neurovascular disease through targeted investments in early stage ventures. 

"We are pleased to have the support of Broadview Ventures with its solid track record of successful investments," shared Amr Salahieh, Founder and Chairman of Shifamed. "In addition, we are grateful for the NSF SBIR Grant that helped fund our breakthrough technology. Apama Medical offers significant medical technology advancement to electrophysiology (EP) therapies and highlights Shifamed's commitment to improving medical procedures in large, proven markets."

Apama Medical, focused on the EP market, offers a vastly superior catheter-based solution for the fastest growing market segment, atrial fibrillation (AF) ablation, which is expected to reach $2.0B in 2017.

"Broadview has a long history of supporting promising medical technology," said Christopher H. Colecchi, Managing Director of Broadview Ventures. "Apama has developed a unique platform in the AF Ablation market. We are excited about continuing our relationship and optimistic about the long-term prospects."

About Shifamed

Shifamed LLC is a privately held medical technology incubator focused on developing new medical products from concept to commercial release. To learn more about Shifamed, please visit www.shifamed.com.

About Apama Medical

Apama Medical is a privately held medical device company formed by Shifamed LLC, a Silicon Valley based medical device incubator. Apama is focused on the rapidly growing electrophysiology (EP) market in which mapping and ablation are estimated to reach $2.0B in 2017. To learn more about Apama Medical, please visit www.apamamedical.com.

About Broadview Ventures

Broadview's mission is to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investments in and support of early stage ventures. To learn more about Broadview Ventures, please visit http://www.broadviewventures.org.

MEDIA CONTACT:
Katie Arnold
SPRIG Consulting LLC
(408) 805-0520
katie@sprigconsulting.com


'/>"/>
SOURCE Shifamed LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Apama Medical Announces Issuance Of Patent For Low Profile Electrodes For Use On Balloons
2. SurgiCount Medical, Inc. announces new 3-year agreement with Novation
3. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
4. Acutus Medical, Inc. bringt 21 Millionen $ für die Serie-B-Finanzierung auf
5. Acutus Medical, Inc. Raises $21 Million Toward its B-Series Financing
6. Astute Medical, Inc. patrocinerà il simposio informativo presso il meeting sulla nefrologia in terapia intensiva
7. Astute Medical, Inc., veranstaltet Symposium aus anlaß des Critical Care Nephrology Kongress
8. Astute Medical, Inc. va accueillir un symposium éducatif lors dune réunion dédiée à la réanimation néphrologique
9. Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.
10. Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference
11. Sequent Medical, Inc. Launches New SL Family of WEB Aneurysm Embolization Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
Breaking Medicine News(10 mins):